fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2009-10-14 III Launch Intercell (Austria)   Travelers' Diarrhea (TD) Vaccine Patch The TD vaccine system consists of a self-adhesive patch containing the vaccine antigen, the LT (heat-labile toxin) from E. coli, and a single-use device used to prepare the skin at the site of patch administration, the Skin Preparation System (SPS). Travelersʹ diarrhea UK, Germany See details
2009-10-13 I Launch BioAlliance Pharma (France)   Fentanyl Lauriad® (sustained release product based on its proprietary muco-adhesive technology already validated with Loramyc®) cancer chronic pain France See details
2009-10-12 I Result Noxxon Pharma (Germany)   NOX-E36 (Spiegelmer® MCP-1 antagonist that specifically targets the pro-inflammatory chemokine monocyte chemoattractant protein-1 (MCP-1), which is also known as CCL2).   UK See details
2009-10-08 I-II Launch NeuroSearch (Denmark)   ACR325 dyskinesia in Parkinson's disease   See details
2009-10-08 I-IIa Launch AC Immune (Switzerland) Bayer Schering Pharma (Germany) ACI-24 (active vaccine stimulating the patient's immune system to produce beta-sheet conformation-specific antibodies that prevent plaque deposition or enhance clearance of plaques) Alzheimer's disease Scandinavia See details
2009-10-07 IIa Result Thrombogenics (Belgium)   microplasmin diabetic macular edema   See details
2009-10-07 I-II Result Paion (Germany)   CNS 7056 (short-acting sedative acting on GABAa receptors in the brain) sedation USA See details
2009-10-07 I Launch Adaptimmune (UK)   T cells carrying an engineered killer T cell receptor to treat HIV (SL9 HA-GAG-TCR) HIV infection - AIDS USA See details
2009-10-07 Other Launch Vernalis (UK)   V3381 (indantadol - NMDA antagonist and MAO-A inhibitor) chronic cough UK See details
2009-09-30 III Result   Novartis (Switzerland) FTY720 (fingolimod - sphingosine 1-phosphate receptor modulator) relapsing-remitting multiple sclerosis   See details
2009-09-29 II Result LifeCycle Pharma (Denmark)   LCP-Tacro® (once-daily tablet version of tacrolimus) prevention of organ rejection in stable liver transplant patients   See details
2009-09-29 I Result Immutep (France)   ImmuFact® IMP321 (T cell immunostimulatory factor, soluble form of LAG-3, protien that binds with a high affinity to MHC class II molecules expressed by dendritic cells and monocytes) advanced renal cell carcinoma France See details
2009-09-24 II Result MolMed (Italy)   NGR-hTNF (vascular targeting agent) malignant pleural mesothelioma   See details
2009-09-24 I Result MolMed (Italy)   NGR-hTNF (vascular targeting agent) solid tumours   See details
2009-09-24 II Result MolMed (Italy)   NGR-hTNF (vascular targeting agent) primary liver carcinoma   See details
[<<]      «      9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19      »      [57]